A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough
Clinical trial NCT02993822 · COMPLETED
Trial details
- NCT number
- NCT02993822
- Sponsor
- Nerre Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2019-01-14
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.